Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study.
Ian PearceAndreas ClemensMichael H BrentLin LuRoberto Gallego-PinazoAngelo Maria MinnellaCatherine P Creuzot GarcherGeorg SpitalTaiji SakamotoCornelia Dunger-BaldaufIan L McAllisternull nullPublished in: PloS one (2020)
One year results from the LUMINOUS real-world study showed a clinically meaningful VA improvement with ranibizumab in treatment-naïve patients with BRVO; numerically higher VA gains were achieved in patients who received more injections and those with poor baseline VA. No new safety signals were observed.